Acid β-glucosidase: insights from structural analysis and relevance to Gaucher disease therapy

Abstract In mammalian cells, glucosylceramide (GlcCer), the simplest glycosphingolipid, is hydrolyzed by the lysosomal enzyme acid β-glucosidase (GlcCerase). In the human metabolic disorder Gaucher disease, GlcCerase activity is significantly decreased owing to one of approximately 200 mutations in the GlcCerase gene. The most common therapy for Gaucher disease is enzyme replacement therapy (ERT), in which patients are given intravenous injections of recombinant human GlcCerase; the Genzyme product Cerezyme® has been used clinically for more than 15 years and is administered to approximately 4000 patients worldwide. Here we review the crystal structure of Cerezyme® and other recombinant forms of GlcCerase, as well as of their complexes with covalent and non-covalent inhibitors. We also discuss the stability of Cerezyme®, which can be altered by modification of its N-glycan chains with possible implications for improved ERT in Gaucher disease.

[1]  N. Radin,et al.  N-hexyl-O-glucosyl sphingosine, an inhibitor of glucosyl ceramide -glucosidase. , 1973, Journal of lipid research.

[2]  G. Semenza,et al.  Stereospecific ring opening of conduritol-B-epoxide by an active site asparatate residue of sucrase-isomaltase. , 1977, Biochimica et biophysica acta.

[3]  R. Desnick,et al.  Human acid beta-glucosidase: inhibition studies using glucose analogues and pH variation to characterize the normal and Gaucher disease glycon binding sites. , 1988, Enzyme.

[4]  R. Van Tiggelen,et al.  Gaucher disease , 2019, Haematology.

[5]  M. Horowitz,et al.  Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease. , 1990, Critical reviews in biochemistry and molecular biology.

[6]  M. Sinnott,et al.  Catalytic mechanism of enzymic glycosyl transfer , 1990 .

[7]  G. Grabowski,et al.  Human acid β-glucosidase: Glycosylation is required for catalytic activity , 1990 .

[8]  M. Horowitz,et al.  Acid β-Glucosidase: Enzymology and Molecular Biology of Gaucher Diseas , 1990 .

[9]  G. Legler.  Glycoside hydrolases: mechanistic information from studies with reversible and irreversible inhibitors. , 1990, Advances in carbohydrate chemistry and biochemistry.

[10]  G. Grabowski,et al.  Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations. , 1990, The Journal of biological chemistry.

[11]  R. B. Trimble,et al.  Identification of distinct endoglycosidase (endo) activities in Flavobacterium meningosepticum: endo F1, endo F2, and endo F3. Endo F1 and endo H hydrolyze only high mannose and hybrid glycans. , 1991, The Journal of biological chemistry.

[12]  K. Han,et al.  Possible relationship between coding recognition amino acid sequence motif or residue(s) and post-translational chemical modification of proteins. , 1992, The International journal of biochemistry.

[13]  K. Han,et al.  Post-translational chemical modification(s) of proteins. , 1992, The International journal of biochemistry.

[14]  Y. Ioannou,et al.  Human acid beta-glucosidase. N-glycosylation site occupancy and the effect of glycosylation on enzymatic activity. , 1993, The Journal of biological chemistry.

[15]  S. Withers,et al.  Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry. , 1994, The Journal of biological chemistry.

[16]  M. Horowitz,et al.  Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease. , 1994, The Biochemical journal.

[17]  B. Henrissat,et al.  Structures and mechanisms of glycosyl hydrolases. , 1995, Structure.

[18]  B. Henrissat,et al.  Conserved catalytic machinery and the prediction of a common fold for several families of glycosyl hydrolases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Greg Grabowski,et al.  Proteolytic Processing Patterns of Prosaposin in Insect and Mammalian Cells* , 1996, The Journal of Biological Chemistry.

[20]  J. E. Johnston,et al.  A novel approach to crystallising proteins under oil , 1996 .

[21]  M. D. Joshi,et al.  The pKa of the general acid/base carboxyl group of a glycosidase cycles during catalysis: a 13C-NMR study of bacillus circulans xylanase. , 1996, Biochemistry.

[22]  R. Salvioli,et al.  Effect of Saposins A and C on the Enzymatic Hydrolysis of Liposomal Glucosylceramide* , 1997, The Journal of Biological Chemistry.

[23]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[24]  J. McPherson,et al.  A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease. , 1999, Blood.

[25]  P. Kaplan,et al.  The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. , 2000, Archives of internal medicine.

[26]  E. Ginns,et al.  Human glucocerebrosidase: heterologous expression of active site mutants in murine null cells. , 2000, Glycobiology.

[27]  G. Arancia,et al.  Saposin D Solubilizes Anionic Phospholipid-containing Membranes* , 2001, The Journal of Biological Chemistry.

[28]  J. Mornon,et al.  [The active site of human glucocerebrosidase: structural predictions and experimental validations]. , 2002, Journal de la Société de Biologie.

[29]  G. Privé,et al.  Crystal structure of saposin B reveals a dimeric shell for lipid binding , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Sylvie Fabrega,et al.  Site actif de la glucocérébrosidase humaine : prédictions structurales et validations expérimentales , 2002 .

[31]  N. Tjandra,et al.  Solution structure of human saposin C: pH-dependent interaction with phospholipid vesicles. , 2003, Biochemistry.

[32]  S. Larson,et al.  First crystallographic structure of a xylanase from glycoside hydrolase family 5: implications for catalysis. , 2003, Biochemistry.

[33]  R. Salvioli,et al.  Interaction of saposin D with membranes: effect of anionic phospholipids and sphingolipids. , 2003, The Biochemical journal.

[34]  J. Sussman,et al.  X‐ray structure of human acid‐β‐glucosidase, the defective enzyme in Gaucher disease , 2003, EMBO reports.

[35]  J. Sussman,et al.  New directions in the treatment of Gaucher disease. , 2004, Trends in pharmacological sciences.

[36]  P. Lerouge,et al.  N-Glycoprotein biosynthesis in plants: recent developments and future trends , 1998, Plant Molecular Biology.

[37]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[38]  V. Gomord,et al.  Posttranslational modification of therapeutic proteins in plants. , 2004, Current opinion in plant biology.

[39]  A. Futerman,et al.  Gaucher disease: pathological mechanisms and modern management , 2005, British journal of haematology.

[40]  H. Bruhn.  A short guided tour through functional and structural features of saposin-like proteins. , 2005, The Biochemical journal.

[41]  Nico Tjandra,et al.  Solution structure of human saposin C in a detergent environment. , 2005, Journal of molecular biology.

[42]  J. Sussman,et al.  X-ray Structure of Human Acid-β-Glucosidase Covalently Bound to Conduritol-B-Epoxide , 2005, Journal of Biological Chemistry.

[43]  J. Sussman,et al.  X-ray structure of human acid-beta-glucosidase covalently bound to conduritol B epoxide , 2005 .

[44]  J. Sussman,et al.  X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease. , 2005, The Journal of biological chemistry.

[45]  M. Zhang,et al.  ANALYSES OF VARIANT ACID β-GLUCOSIDASES : EFFECTS OF GAUCHER DISEASE MUTATIONS † , 2005 .

[46]  W. Sly,et al.  Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Wendeler,et al.  Characterization of human saposins by NMR spectroscopy. , 2006, Biochemistry.

[48]  G. Privé,et al.  Crystal structures of saposins A and C , 2006, Protein science : a publication of the Protein Society.

[49]  Min Zhang,et al.  Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations. , 2006, The Journal of biological chemistry.

[50]  Joel L Sussman,et al.  Structural comparison of differently glycosylated forms of acid-beta-glucosidase, the defective enzyme in Gaucher disease. , 2006, Acta crystallographica. Section D, Biological crystallography.

[51]  C. Yip,et al.  Molecular imaging of membrane interfaces reveals mode of β-glucosidase activation by saposin C , 2007, Proceedings of the National Academy of Sciences.

[52]  Gregory A Petsko,et al.  Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease. , 2006, Nature chemical biology.

[53]  Shadi Abu-Baker,et al.  Investigating the interaction of saposin C with POPS and POPC phospholipids: a solid-state NMR spectroscopic study. , 2007, Biophysical journal.

[54]  S. Withers,et al.  Structural and Mechanistic Analyses of endo-Glycoceramidase II, a Membrane-associated Family 5 Glycosidase in the Apo and GM3 Ganglioside-bound Forms* , 2007, Journal of Biological Chemistry.

[55]  Joel L Sussman,et al.  Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease. , 2007, The Journal of biological chemistry.

[56]  O. Dym,et al.  Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. , 2007, Plant biotechnology journal.

[57]  R. Schultz-Heienbrok,et al.  Crystal structures of human saposins C andD: implications for lipid recognition and membrane interactions. , 2008, Structure.

[58]  M. Plebani.  Article in press-uncorrected proof , 2010 .